Report Categories
View AllRecent Articles
View All
LITE Lumentum Holdings posts 174 percent Q1 2026 EPS beat shares rise 41 percent on positive investor sentiment
HTZWW Hertz highlights positive travel sector trends in its newly released quarterly earnings report
The macro factors Stoke Therapeutics STOK discussed in earnings Q4 2025 Profit Disappoints
Fonterra Cooperative Group Limited FCG 81 Yield Positioning Amid Expanding Asian Dividend Investment Opportunities
Consumer Credit Growth Accelerates in December Signaling Robust Spending
Shell Shares Upgraded to Buy After ARC Resources Transaction
Barclays Initiates ClevelandCliffs Coverage with Underweight Rating Cites Higher Leverage Concerns
US Jobless Claims Remain at Historically Low Levels Signaling Labor Market Strength
An Investors Field Guide to ETF Structures Navigating OpenEnd UIT Grantor Trust and ETN Models
Eli Lilly Positioned as Potential SafeHaven Stock for LongTerm Investors in 2026
FRAF Q1 2026 Earnings EPS Surpasses Estimates by 828 Stock Edges Lower
YALA Q1 2026 Earnings EPS of 016 Reported Stock Declines Amid Limited Guidance
SCYX Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite WiderThanExpected Loss
PLDT Inc PHI Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady
MDLN Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response
ATI Q1 2026 Earnings Strong EPS Surprise of 124 Outpaces Analyst Expectations Stock Edges Lower
Reservoir Media Inc RSVR Holds Steady at 1020 as Market Awaits Catalysts
Serina Therapeutics SER Faces Headwinds Shares Decline 3 Toward Support at 182
Silicon Laboratories Inc SLAB Edges Lower Consolidates Near Support at 207
Northern Oil and Gas NOG Holds Steady Near Support Eyes Key Resistance
DRTSW Plunges 14 as Selling Pressure Intensifies Key Support Levels in Focus
Vanda Pharmaceuticals Q1 2026 Earnings EPS Misses Estimates Stock Advances Despite Wider Loss
Xylem Q1 2026 Earnings EPS Slightly Above Estimates Amid Operational Strength
Energy Focus EFOI Q4 2024 Earnings Narrower Loss Amid Operational Adjustments Shares Edge Higher
MITP Q1 2026 Earnings EPS Surpasses Estimates by 535
Aditxt Inc ADTX Q3 2025 Earnings Significant Loss Per Share and No Revenue Amid Sharp Stock Decline
Compass Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Pipeline Progress